tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Shanghai Henlius Biotech Secures FDA Orphan-drug Designation for HLX43
PremiumCompany AnnouncementsShanghai Henlius Biotech Secures FDA Orphan-drug Designation for HLX43
2M ago
Shanghai Henlius Biotech’s HANSIZHUANG Shows Promising Results in Gastric Cancer Treatment
Premium
Company Announcements
Shanghai Henlius Biotech’s HANSIZHUANG Shows Promising Results in Gastric Cancer Treatment
2M ago
Shanghai Henlius Biotech Advances in Oncology with New Clinical Trial Approval
Premium
Company Announcements
Shanghai Henlius Biotech Advances in Oncology with New Clinical Trial Approval
2M ago
Shanghai Henlius Biotech’s HLX17 Receives FDA Approval for Clinical Trials
PremiumCompany AnnouncementsShanghai Henlius Biotech’s HLX17 Receives FDA Approval for Clinical Trials
3M ago
Shanghai Henlius Biotech Receives FDA Approval for Two Biosimilars
Premium
Company Announcements
Shanghai Henlius Biotech Receives FDA Approval for Two Biosimilars
3M ago
Shanghai Henlius Biotech Confirms Leadership Continuity with Board Re-appointments
Premium
Company Announcements
Shanghai Henlius Biotech Confirms Leadership Continuity with Board Re-appointments
3M ago
Shanghai Henlius Biotech Advances HLX43 Clinical Trials in the US
PremiumCompany AnnouncementsShanghai Henlius Biotech Advances HLX43 Clinical Trials in the US
3M ago
Shanghai Henlius Biotech Clarifies Member Register Closure Procedures
Premium
Company Announcements
Shanghai Henlius Biotech Clarifies Member Register Closure Procedures
4M ago
Shanghai Henlius Biotech’s New Drug Application for HLX04-O Accepted by NMPA
Premium
Company Announcements
Shanghai Henlius Biotech’s New Drug Application for HLX04-O Accepted by NMPA
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100